Geoffrey S. Gilmartin
Geen lopende functies
Profiel
Geoffrey S.
Gilmartin worked as a Medical Director-Clinical Development at Vertex Pharmaceuticals, Inc. from 2011 to 2014.
He also worked as the Director of BIDMC Sleep Disorders Center at Beth Israel Deaconess Medical Center, Inc. Additionally, he was the Chief Medical Affairs Officer at Proteostasis Therapeutics, Inc. in 2019.
Gilmartin received his undergraduate degree from Dartmouth College, his graduate degree from Harvard Medical School, and his doctorate from The Warren Alpert Medical School.
Eerdere bekende functies van Geoffrey S. Gilmartin
| Bedrijven | Functie | Einde |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 01-01-2014 |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
| PROTEOSTASIS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Geoffrey S. Gilmartin
| Dartmouth College | Undergraduate Degree |
| Harvard Medical School | Graduate Degree |
| The Warren Alpert Medical School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Health Services |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
